Clinical Trial Update: A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

This is an update on a Phase 1 safety trial to determine the maximum tolerated dose of elesclomol sodium in patients with metastatic solid tumors, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Elesclomol Sodium (elesclomol)

Snippet

Sponsor: Synta Pharmaceuticals Corp. | Conditions: Metastatic Solid Tumors | Phase 1 | Status: SUSPENDED